Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
Year: 2005
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Ludwig-Maximilians-Universität München
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W126855108
